通过C肽免疫反应性评估胰岛素治疗的糖尿病患者β细胞功能的序贯变化。 - Suppr

Suppr

超能文献

Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.

作者信息

Block M B, Rosenfield R L, Mako M E, Steiner D F, Rubenstein A H

出版信息

N Engl J Med. 1973 May 31;288(22):1144-8. doi: 10.1056/NEJM197305312882202.

DOI:10.1056/NEJM197305312882202

PMID:4633551

Abstract

摘要

相似文献

Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.

N Engl J Med. 1973 May 31;288(22):1144-8. doi: 10.1056/NEJM197305312882202.

Effect of control of hyperglycemia on plasma insulin responses to various stimuli in newly diagnosed ketosis-prone diabetic patients.

J Clin Endocrinol Metab. 1972 Aug;35(2):288-98. doi: 10.1210/jcem-35-2-288.

Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients.

Diabetes. 1972 Oct;21(10):1013-26. doi: 10.2337/diab.21.10.1013.

Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery.

J Clin Endocrinol Metab. 1972 Sep;35(3):402-6. doi: 10.1210/jcem-35-3-402.

[Remission of diabetes mellitus in children and adults].

Ter Arkh. 1972 Oct;44(10):3-8.

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

N Engl J Med. 1970 Jul 16;283(3):109-15. doi: 10.1056/NEJM197007162830301.

Use of an artificial beta cell in surgery.

Horm Metab Res Suppl. 1979(8):156-8.

C-peptide response to glycaemic stimuli.

J Assoc Physicians India. 1987 May;35(5):362-4.

Observations on B-cell function after segmental pancreatic allotransplantation in diabetic patients.

Horm Metab Res Suppl. 1983(13):42-6.

[C-peptide and insulin in diabetics].

Zhonghua Yi Xue Za Zhi. 1982 Nov;62(11):651-6.

引用本文的文献

Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis.

bioRxiv. 2025 Mar 1:2024.12.29.630665. doi: 10.1101/2024.12.29.630665.

β-Cell Heterogeneity and Plasticity.

Adv Anat Embryol Cell Biol. 2024;239:57-90. doi: 10.1007/978-3-031-62232-8_3.

C-peptide and residual β-cell function in pediatric diabetes - state of the art.

Pediatr Endocrinol Diabetes Metab. 2021;27(2):123-133. doi: 10.5114/pedm.2021.107165.

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?

Biomedicines. 2020 May 3;8(5):108. doi: 10.3390/biomedicines8050108.

[Not Available].

Maedica (Bucur). 2019 Mar;14(1):53-58. doi: 10.26574/maedica.2019.14.1.53.

Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.

Mol Metab. 2017 Jul 8;6(9):943-957. doi: 10.1016/j.molmet.2017.06.019. eCollection 2017 Sep.

Combination immunotherapies for type 1 diabetes mellitus.

Nat Rev Endocrinol. 2015 May;11(5):289-97. doi: 10.1038/nrendo.2015.8. Epub 2015 Feb 17.

Introduction of Arthur H. Rubenstein.

J Clin Invest. 2012 Nov;122(11):4283-8. doi: 10.1172/JCI66849. Epub 2012 Nov 1.

Size-controlled insulin-secreting cell clusters.

Acta Biomater. 2012 Dec;8(12):4278-84. doi: 10.1016/j.actbio.2012.08.010. Epub 2012 Aug 14.

C-peptide in the natural history of type 1 diabetes.

Diabetes Metab Res Rev. 2009 May;25(4):325-8. doi: 10.1002/dmrr.943.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.

N Engl J Med. 1973 May 31;288(22):1144-8. doi: 10.1056/NEJM197305312882202.

Effect of control of hyperglycemia on plasma insulin responses to various stimuli in newly diagnosed ketosis-prone diabetic patients.

J Clin Endocrinol Metab. 1972 Aug;35(2):288-98. doi: 10.1210/jcem-35-2-288.

Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients.

Diabetes. 1972 Oct;21(10):1013-26. doi: 10.2337/diab.21.10.1013.

Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery.

J Clin Endocrinol Metab. 1972 Sep;35(3):402-6. doi: 10.1210/jcem-35-3-402.

[Remission of diabetes mellitus in children and adults].

Ter Arkh. 1972 Oct;44(10):3-8.

Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

N Engl J Med. 1970 Jul 16;283(3):109-15. doi: 10.1056/NEJM197007162830301.

Use of an artificial beta cell in surgery.

Horm Metab Res Suppl. 1979(8):156-8.

C-peptide response to glycaemic stimuli.

J Assoc Physicians India. 1987 May;35(5):362-4.

Observations on B-cell function after segmental pancreatic allotransplantation in diabetic patients.

Horm Metab Res Suppl. 1983(13):42-6.

[C-peptide and insulin in diabetics].

Zhonghua Yi Xue Za Zhi. 1982 Nov;62(11):651-6.

引用本文的文献

Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis.

bioRxiv. 2025 Mar 1:2024.12.29.630665. doi: 10.1101/2024.12.29.630665.

β-Cell Heterogeneity and Plasticity.

Adv Anat Embryol Cell Biol. 2024;239:57-90. doi: 10.1007/978-3-031-62232-8_3.

C-peptide and residual β-cell function in pediatric diabetes - state of the art.

Pediatr Endocrinol Diabetes Metab. 2021;27(2):123-133. doi: 10.5114/pedm.2021.107165.

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?

Biomedicines. 2020 May 3;8(5):108. doi: 10.3390/biomedicines8050108.

[Not Available].

Maedica (Bucur). 2019 Mar;14(1):53-58. doi: 10.26574/maedica.2019.14.1.53.

Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.

Mol Metab. 2017 Jul 8;6(9):943-957. doi: 10.1016/j.molmet.2017.06.019. eCollection 2017 Sep.

Combination immunotherapies for type 1 diabetes mellitus.

Nat Rev Endocrinol. 2015 May;11(5):289-97. doi: 10.1038/nrendo.2015.8. Epub 2015 Feb 17.

Introduction of Arthur H. Rubenstein.

J Clin Invest. 2012 Nov;122(11):4283-8. doi: 10.1172/JCI66849. Epub 2012 Nov 1.

Size-controlled insulin-secreting cell clusters.

Acta Biomater. 2012 Dec;8(12):4278-84. doi: 10.1016/j.actbio.2012.08.010. Epub 2012 Aug 14.

C-peptide in the natural history of type 1 diabetes.

Diabetes Metab Res Rev. 2009 May;25(4):325-8. doi: 10.1002/dmrr.943.